CTOR
Citius Oncology·NASDAQ
--
--(--)
--
--(--)
CTOR fundamentals
Citius Oncology (CTOR) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.08 (YoY --), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.08
--
Report date
Aug 12, 2025
Earnings
EPS
Revenue
Revenue & Expenses
CTOR has released its 2026 Q1 earnings report, with revenue of 3.94M, reflecting a YoY change of NaN%, and net profit of -5.53M, showing a YoY change of 16.90%. The Sankey diagram below clearly presents CTOR's revenue sources and cost distribution.
Key Indicators
Citius Oncology (CTOR) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Citius Oncology (CTOR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Citius Oncology (CTOR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Citius Oncology (CTOR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Citius Oncology (CTOR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Citius Oncology (CTOR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Citius Oncology next quarter?What is the revenue and EPS growth rate for Citius Oncology year over year?What were the key takeaways from Citius Oncology's earnings call?What is Citius Oncology's latest dividend and current dividend yield?What does Citius Oncology do and what are its main business segments?Did Citius Oncology beat or miss consensus estimates last quarter?What is Citius Oncology's gross profit margin?What guidance did Citius Oncology's management provide for the next earnings period?
